Moberg Pharma AB (SEK)
MOB
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range14.69 | 15.00
52-Wk Range- | -
Last Close14.90
Mkt Cap (m)278.68
Dividend yield-
ISINSE0013121340
Volume47,494.00
Exchange VenueSTO

Company Profile

Moberg Pharma AB is a pharmaceutical company. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus.

Key Information
Price/Earning8.05
Price/Book0.84
Price/Sales0.57
P/CF2.97
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Annual Report
en 31/12/2018

Please refer to the below issuer website for further documents.

http://www.mobergpharma.se

Financials

Income Statement
SEK201420152016201720182019
Revenue (m)200.18285.57334.30439.03439.04-
Operating Income (m)11.9629.6815.1737.2654.76-
Net Income (m)12.2725.5432.6711.1619.84-
Basic EPS0.961.802.270.641.14-
Avg. Diluted Shares Outstanding (m)12.8614.3914.5017.5517.46-
Balance Sheet
SEK201420152016201720182019
Current Assets (m)117.45119.11220.87233.40211.95-
Non Current Assets (m)242.28278.341,011.30989.851,039.66-
Total Assets (m)359.72397.451,232.181,223.261,251.61-
Current Liabilities (m)52.6444.6374.5473.6956.16-
Total Liabilities (m)------
Total Equity (m)303.75352.82561.63552.41594.02-
Cash Flows
SEK201420152016201720182019
Operating Cash Flows (m)16.1630.72-17.9453.8273.89-
Capital Expenditure (m)-7.27-43.88-680.66-19.68-83.64-
Figures are quoted in SEK unless stated otherwise
-
No change
14.90
Last Price